Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Poeschel · SciRah

Researcher profile · Semantic Scholar

V. Poeschel

Share profile

V. Poeschel — researcher profile on SciRah

h-index: 20
Works: 87
Citations: 3,674

Most-cited papers

Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
M. Pfreundschuh, J. Schubert, M. Ziepert, R. Schmits +22 more
2008The Lancet Oncology1,097 citations
Semantic Scholar
CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group.
M. Pfreundschuh, E. Kuhnt, L. Trumper, A. Osterborg +17 more
2011The Lancet Oncology751 citations
Semantic Scholar
International prognostic indices in diffuse large B-cell lymphoma (DLBCL): a comparison of IPI, R-IPI and NCCN-IPI.
A. Ruppert, J. Dixon, G. Salles, Anna K. M. Wall +10 more
2020Blood313 citations Open access
Semantic Scholar
The role of sex and weight on rituximab clearance and serum elimination half-life in elderly patients with DLBCL.
Carsten Müller, N. Murawski, M. Wiesen, G. Held +11 more
2012Blood250 citations Open access
Semantic Scholar
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
V. Poeschel, G. Held, M. Ziepert, M. Witzens-Harig +40 more
2019The Lancet208 citations Open access
Semantic Scholar
Suboptimal dosing of rituximab in male and female patients with DLBCL.
M. Pfreundschuh, Carsten Müller, S. Zeynalova, E. Kuhnt +8 more
2014Blood134 citations
Semantic Scholar
Optimization of rituximab for the treatment of diffuse large B-cell lymphoma (II): extended rituximab exposure time in the SMARTE-R-CHOP-14 trial of the german high-grade non-Hodgkin lymphoma study group.
M. Pfreundschuh, V. Poeschel, S. Zeynalova, M. Hänel +13 more
2014Journal of Clinical Oncology87 citations Open access
Semantic Scholar
Six, Not Eight Cycles of Bi-Weekly CHOP with Rituximab (R-CHOP-14) Is the Preferred Treatment for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
M. Pfreundschuh, M. Kloess, R. Schmits, S. Zeynalova +21 more
200564 citations
Semantic Scholar
Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma.
Annegret Reichwagen, M. Ziepert, M. Kreuz, Ute Gödtel-Armbrust +10 more
2015Pharmacogenomics (London)53 citations
Semantic Scholar
Six versus eight cycles of biweekly CHOP-14 with or without R in elderly patients (pts) with aggressive CD20+ B-cell lymphomas: Seven-year FU of the RICOVER-60 trial of the DSHNHL.
M. Pfreundschuh, M. Ziepert, S. Zeynalova, E. Lengfelder +12 more
2011Journal of Clinical Oncology51 citations
Semantic Scholar
Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.
M. Pfreundschuh, N. Murawski, M. Ziepert, B. Altmann +15 more
201843 citations
Semantic Scholar
Six vs. Eight Cycles of Bi-Weekly CHOP-14 with or without Rituximab for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of the Completed RICOVER-60 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
M. Pfreundschuh, M. Kloess, S. Zeynalova, E. Lengfelder +18 more
200639 citations
Semantic Scholar
A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL.
N. Schmitz, Lorenz Trumper, K. Bouabdallah, M. Ziepert +37 more
2020Blood35 citations Open access
Semantic Scholar
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
A. Staiger, M. Altenbuchinger, M. Ziepert, Christian W. Kohler +20 more
2019Leukemia32 citations Open access
Semantic Scholar
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
D. Kaddu-Mulindwa, B. Altmann, G. Held, Stephanie Angel +15 more
2021European Journal of Nuclear Medicine and Molecular Imaging31 citations Open access
Semantic Scholar
Hyper-N-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma.
L. Thurner, K. Preuss, M. Bewarder, Maria Kemele +25 more
2018Blood31 citations Open access
Semantic Scholar
Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: Results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL>60 study of the DSHNHL.
M. Pfreundschuh, Konstantinos Christofyllakis, B. Altmann, M. Ziepert +16 more
201730 citations
Semantic Scholar
Improved outcome of elderly patients with poor-prognosis diffuse large B-cell lymphoma (DLBCL) after dose-dense rituximab: Results of the DENSE-R-CHOP-14 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL)
M. Pfreundschuh, S. Zeynalova, V. Poeschel, M. Haenel +5 more
200829 citations
Semantic Scholar
Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes
D. Noerenberg, F. Briest, C. Hennch, Kenichi Yoshida +29 more
2023Journal of Clinical Oncology25 citations
Semantic Scholar
SPARC positive macrophages are the superior prognostic factor in the microenvironment of diffuse large B-cell lymphoma and independent of MYC rearrangement and double/triple hit status.
G. Croci, R. Au-Yeung, S. Reinke, A. Staiger +13 more
2021Annals of Oncology22 citations Open access
Semantic Scholar
R/R-IPI: An international prognostic calculator for relapsed/refractory diffuse large B-cell lymphoma
M. Maurer, L. Jakobsen, Raphael Mwangi, N. Schmitz +19 more
2021American journal of hematology/oncology20 citations Open access
Semantic Scholar
The Role of Radiotherapy to Bulky Disease in the Rituximab Era: Results from Two Prospective Trials of the German High-Grade Non-Hodgkin- Lymphoma Study Group (DSHNHL) for Elderly Patients with DLBCL
M. Pfreundschuh, M. Ziepert, M. Reiser, V. Poeschel +7 more
200820 citations
Semantic Scholar
Landscape of 4D Cell Interaction in Hodgkin and Non-Hodgkin Lymphomas
S. Hartmann, S. Scharf, Yvonne Steiner, A. Loth +13 more
2021Cancers18 citations Open access
Semantic Scholar
B-cell receptor reactivity against Rothia mucilaginosa in nodular lymphocyte-predominant Hodgkin lymphoma
L. Thurner, N. Fadle, Evi Regitz, Sophie Roth +23 more
2023Haematologica17 citations Open access
Semantic Scholar
Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA
V. Poeschel, G. Held, M. Ziepert, B. Altmann +21 more
2018Blood17 citations
Semantic Scholar
Optimization of rituximab for the treatment of DLBCL (I): dose-dense rituximab in the DENSE-R-CHOP-14 trial of the DSHNHL.
N. Murawski, M. Pfreundschuh, S. Zeynalova, V. Poeschel +10 more
201417 citations Open access
Semantic Scholar
Male Sex Is Associated with Lower Rituximab Trough Serum Levels and Evolves as a Significant Prognostic Factor in Elderly Patients with DLBCL Treated with R-CHOP: Results From 4 Prospective Trials of the German High-Grade Non-Hodgkin-Lymphoma Study Group (DSHNHL).
M. Pfreundschuh, N. Murawski, S. Zeynalova, V. Poeschel +9 more
200917 citations
Semantic Scholar
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma)
O. Tournilhac, B. Altmann, B. Friedrichs, K. Bouabdallah +38 more
2024Journal of Clinical Oncology16 citations
Semantic Scholar
Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration
F. Frontzek, L. Renaud, U. Duhrsen, V. Poeschel +25 more
2024Leukemia15 citations
Semantic Scholar
Radiation and Dose-densification of R-CHOP in Aggressive B-cell Lymphoma With Intermediate Prognosis: The UNFOLDER Study
L. Thurner, M. Ziepert, C. Berdel, C. Schmidt +43 more
2023HemaSphere15 citations Open access
Semantic Scholar
Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group
K. Hohloch, M. Ziepert, L. Truemper, C. Buske +4 more
2020eJHaem15 citations Open access
Semantic Scholar
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER Trial
G. Held, L. Thurner, V. Poeschel, G. Ott +29 more
2023HemaSphere14 citations Open access
Semantic Scholar
Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: A subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA).
G. Held, L. Thurner, V. Poeschel, C. Berdel +16 more
202013 citations
Semantic Scholar
Central nervous system relapse in younger patients with diffuse large B-cell lymphoma: a LYSA and GLA/DSHNHL analysis
C. Thieblemont, B. Altmann, F. Frontzek, L. Renaud +18 more
2023Blood Advances12 citations Open access
Semantic Scholar
LRPAP1-autoantibodies in mantle cell lymphoma are associated with superior outcome.
L. Thurner, N. Fadle, J. Bittenbring, Evi Regitz +16 more
2021Blood12 citations Open access
Semantic Scholar
Dose-Dense Rituximab Improves Outcome of Elderly Patients with Poor-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL): Results of the DENSE-R-CHOP-14 Trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
M. Pfreundschuh, S. Zeynalova, V. Poeschel, M. Haenel +5 more
200712 citations
Semantic Scholar
Dose-Dense Rituximab in Combination with Biweekly CHOP-14 for Elderly Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Phase-I/II and Pharmacokinetic Study of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL).
V. Poeschel, M. Nickelsen, M. Hänel, S. Kremers +7 more
200610 citations
Semantic Scholar
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Stuttgart, 29. September-3. Oktober 2017: Abstracts
N. Murawski, Josif Amam, B. Altmann, M. Ziepert +13 more
2017Oncology Research and Treatment8 citations Open access
Semantic Scholar
KIR2DS1-HLA-C status as a predictive marker for benefit from rituximab: a post-hoc analysis of the RICOVER-60 and CLL8 trials.
D. Kaddu-Mulindwa, B. Altmann, S. Robrecht, M. Ziepert +18 more
2022The Lancet Haematology7 citations
Semantic Scholar
R-GemOx Plus Nivolumab Vs R-GemOx As Second-Line Therapy for Large B-Cell Lymphoma in Transplant-Ineligible Patients: Interim Analysis of the Niveau Trial, an International, Randomized Phase 3 Study of the AGMT, GLA, HOVON, Lysa and PLRG
Gerhard Held, B. Altmann, Andrea Kerkhoff, T. Gastinne +28 more
2023Blood6 citations
Semantic Scholar
Radiotherapy in younger patients with advanced aggressive B-cell lymphoma—long-term results from the phase 3 R-MegaCHOEP trial
M. Oertel, M. Ziepert, F. Frontzek, N. Nacke +8 more
2024Leukemia5 citations Open access
Semantic Scholar
An inherited genetic variant of the CEP72 gene is associated with the development of vincristine-induced peripheral neuropathy in female patients with aggressive B-cell lymphoma
Konstantinos Christofyllakis, D. Kaddu-Mulindwa, V. Lesan, Torben M. Rixecker +10 more
2024Annals of Hematology5 citations Open access
Semantic Scholar
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma
R. Houot, V. Poeschel, B. Altmann, Stephanie Angel +25 more
2022HemaSphere5 citations Open access
Semantic Scholar
First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial
F. Braulke, F. Zettl, M. Ziepert, A. Viardot +17 more
2022HemaSphere5 citations Open access
Semantic Scholar
Prevalence of Anti-Citrullinated Protein Antibodies (ACPA) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL): A Case-Control Study
G. Assmann, K. Shihadeh, V. Poeschel, N. Murawski +3 more
2014PLoS ONE5 citations Open access
Semantic Scholar
A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1)
Konstantinos Christofyllakis, V. Poeschel, B. Altmann, Stephanie Maurer +30 more
2023Blood4 citations Open access
Semantic Scholar
Significant reduced loss of bone mineral density after four vs. six cycles of R-CHOP: an analysis of the FLYER-trial
D. Kaddu-Mulindwa, V. Lesan, C. Berdel, S. Stilgenbauer +13 more
2021Leukemia and Lymphoma4 citations
Semantic Scholar
Age and Time to Progression Predict Overall Survival (OS) in Patients with Diffuse Large B-Cell Lymphoma (DLBCL) Who Progress Following Frontline Immunochemotherapy (IC)
M. Maurer, L. Jakobsen, N. Schmitz, U. Farooq +18 more
2019Blood4 citations Open access
Semantic Scholar
Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study
Z. G. Dilbaz, S. Denker, Carla Ankermann, J. Bittenbring +9 more
2024European Journal of Haematology3 citations Open access
Semantic Scholar
A Simplified IPI Including BCL2 Identifies IPI 3 Patients with Poor Prognosis - a GLA/ Dshnhl and Lysa Collaboration
M. Ziepert, B. Altmann, V. Poeschel, C. Cristinelli +16 more
2023Blood3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Ziepert×33
Invite
M. Ziepert — researcher profile on SciRah
N. Schmitz×25
Invite
N. Schmitz — researcher profile on SciRah
B. Altmann×22
Invite
B. Altmann — researcher profile on SciRah
M. Pfreundschuh×21
Invite
M. Pfreundschuh — researcher profile on SciRah

×20

Invite

G. Held — researcher profile on SciRah

Invite

L. Thurner — researcher profile on SciRah

N. Murawski×16

Invite

N. Murawski — researcher profile on SciRah

Invite

A. Viardot — researcher profile on SciRah

L. Truemper×14

Invite

L. Truemper — researcher profile on SciRah

M. Loeffler×12

Invite

M. Loeffler — researcher profile on SciRah

M. Bewarder×12

Invite

M. Bewarder — researcher profile on SciRah

Invite

B. Metzner — researcher profile on SciRah